Biocryst Pharmaceuticals Inc (BCRX) returns
Biocryst Pharmaceuticals returns over 10 years
$1,000 invested in Biocryst Pharmaceuticals ten years ago was worth $2,061 at the close on October 30, 2026, with dividends reinvested: an average return of 7.5% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +1.7% | — | $1,017 | -0.9% |
| 3 months | -8.3% | — | $916.67 | +2.1% |
| Year to date | +8.6% | — | $1,086 | +11.7% |
| 1 year | +16.8% | — | $1,168 | +12.4% |
| 3 years | +54.3% | +15.6% | $1,543 | +88.5% |
| 5 years | -43.3% | -10.7% | $567.31 | +76.0% |
| 10 years | +106.1% | +7.5% | $2,061 | +316.6% |
Biocryst Pharmaceuticals return by calendar year
| Year | BCRX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +8.6% | +11.7% | -3.1% |
| 2025 | +3.7% | +17.7% | -14.0% |
| 2024 | +25.5% | +24.9% | +0.7% |
| 2023 | -47.8% | +26.2% | -74.0% |
| 2022 | -17.1% | -18.2% | +1.1% |
| 2021 | +85.9% | +28.7% | +57.2% |
| 2020 | +115.9% | +18.4% | +97.6% |
| 2019 | -57.2% | +31.2% | -88.5% |
| 2018 | +64.4% | -4.6% | +68.9% |
| 2017 | -22.4% | +21.7% | -44.1% |
| 2016 | -38.7% | +12.0% | -50.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: BCRX financials
No forecast, no recommendation. This page describes Biocryst Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.